Abstract
Rationale
Depression is a major mental disorder affecting millions of people worldwide. Serotonin and norepinephrine reuptake inhibitors (SNRIs) are one of the antidepressant drugs prescribed for depression treatment.
Objective and method
There are many contradiction studies about the adverse effect and genotoxicity of SNRIs. So here, based on the guidelines proposed at the PRISMA statement, we performed a quantitative systematic review by searching international electronic databases (PubMed, Scopus, Embase, and Web of Science) for published documents on SSNRIs and their genotoxicity effects.
Results
The database searches retrieved 336 records, 18 of which met the inclusion criteria. Evaluation of the selected articles showed that a total of 9 articles were appropriate for final review. Most of these studies (78%) reported positive results for the genotoxicity of SNRIs
Conclusion
Finally, we can conclude that these drugs have the potential to damage DNA.
Similar content being viewed by others
References
Abdel-Wahab BA, Salama RH (2011) Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice. Pharmacol Biochem Behav 100(1):59–65
Ahmadimanesh M, Abbaszadegan MR, Morshedi Rad D, Moallem SA, Mohammadpour AH, Ghahremani MH, Farid Hosseini F, Behdani F, Akhondpour Manteghi A, Jowsey P, Shabani Behbahani F, Moallem SMH, Etemad L (2019) Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression. J Psychopharmacol 33(11):1364–1376
Avuloglu Yilmaz E, Unal F, Yuzbasioglu D (2017) Evaluation of cytogenetic and DNA damage induced by the antidepressant drug-active ingredients, trazodone and milnacipran, in vitro. Drug Chem Toxicol 40(1):57–66
Ayabaktı S, Yavuz Kocaman A (2018) Cytogenotoxic effects of venlafaxine hydrochloride on cultured human peripheral blood lymphocytes. Drug Chem Toxicol:1–8
Bindoli A, Rigobello MP, Deeble DJ (1992) Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 13(4):391–405
Bôaventura CS, Guimarães AN, Soares GR, Fraga AMBF, Neves FBCS, Pondé MP (2007) Risk of cancer associated with the use of antidepressants. Rev Psiquiatr Rio Gd Sul 29(1):63–69
Bourin M (2012) Serotonin noradrenaline reuptake inhibitors, Future Medicine
Brambilla G, Martelli A (2007) Genotoxic and carcinogenic risk to humans of drug–nitrite interaction products. Mutat Res Rev Mutat Res 635(1):17–52
Brambilla G, Mattioli F, Martelli A (2009) Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology 261(3):77–88
Elias E et al (2017) Assessment of genotoxic effect induced by some antidepressant drugs employing a variety of short-term genotoxic bioassays. Alex Sci Exch J 38(April–June):185–192
Gupta S, Nihalani N, Masand P (2007) Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. Ann Clin Psychiatry 19(2):125–132
Halliwell B (2001) Role of free radicals in the neurodegenerative diseases. Drugs Aging 18(9):685–716
Hunziker ME, Suehs BT, Bettinger TL, Crismon ML (2005) Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder. Clin Ther 27(8):1126–1143
Jenkins G et al (2005) Do dose response thresholds exist for genotoxic alkylating agents? Mutagenesis 20(6):389–398
Jost WH, Marsalek P (2005) Duloxetine in the treatment of stress urinary incontinence. Ther Clin Risk Manag 1(4):259
Kang SH, Kwon JY, Lee JK, Seo YR (2013) Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models. J Cancer Prev 18(4):277–288
Lacaze E, Pédelucq J, Fortier M, Brousseau P, Auffret M, Budzinski H, Fournier M (2015) Genotoxic and immunotoxic potential effects of selected psychotropic drugs and antibiotics on blue mussel (Mytilus edulis) hemocytes. Environ Pollut 202:177–186
Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J (2017) Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry 74(10):1011–1020
Madrigal-Bujaidar E, Álvarez-González I, Madrigal-Santillán EO, Morales-González JA (2015) Evaluation of duloxetine as micronuclei inducer in an acute and a subchronic assay in mouse. Biol Pharm Bull 38(8):1245–1249
Madrigal-Bujaidar E, Álvarez-González I, Madrigal-Santillán EO, Morales-González JA, Torres-Gómez A, Cristóbal-Luna JM (2017) Genotoxic evaluation of duloxetine II. The effect on the number of sister chromatid exchanges, the mitotic index, and the proliferation kinetics in mouse bone marrow. Biol Pharm Bull 40(10):1796–1800
Mateuca RA, Decordier I, Kirsch-Volders M (2012) Cytogenetic methods in human biomonitoring: principles and uses, in Genetic Toxicology, Springer. p. 305–334
Metcalfe CD, Chu S, Judt C, Li H, Oakes KD, Servos MR, Andrews DM (2010) Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ Toxicol Chem 29(1):79–89
Pereira P et al (2005) Neurobehavioral and genotoxic aspects of rosmarinic acid. Pharmacol Res 52(3):199–203
Pereira P et al (2009) Neurobehavioral and genotoxic parameters of duloxetine in mice using the inhibitory avoidance task and comet assay as experimental models. Pharmacol Res 59(1):57–61
Puyo S, Montaudon D, Pourquier P (2014) From old alkylating agents to new minor groove binders. Crit Rev Oncol Hematol 89(1):43–61
Rénéric J-P, Lucki I (1998) Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology 136(2):190–197
Rueter LE, Kasamo K, de Montigny C, Blier P (1998) Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain. Naunyn Schmiedeberg's Arch Pharmacol 357(6):600–610
Silva AM, Barbosa IA, Seabra C, Beltrão N, Santos R, Vega-Naredo I, Oliveira PJ, Cunha-Oliveira T (2016) Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity. Food Chem Toxicol 94:148–158
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3):206–221
Wilson DM III, Thompson LH (2007) Molecular mechanisms of sister-chromatid exchange. Mutat Res Fundam Mol Mech Mutagen 616(1–2):11–23
Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z (2017) A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis Treat 13:2781–2796
Funding
Mazandaran University of Medical Sciences provided financial support of this study by Grant No. 7082.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interest
The authors declare that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ahmadimanesh, M., Balarastaghi, S., Rashedinia, M. et al. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants. Psychopharmacology 237, 1909–1915 (2020). https://doi.org/10.1007/s00213-020-05550-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-020-05550-8